Status
Conditions
Treatments
About
The present study aims to evaluate the effectiveness of two different exergaming systems in addition to conventional treatment on physical functional capacity, balance, muscle strength, spasticity in lower limbs and quality of life compared to an isolated conventional intervention in patients with multiple sclerosis. The secondary aim will be to compare the differences between both exergaming groups.
Full description
Multiple sclerosis is a chronic autoimmune inflammatory disease of the central nervous system, which produces demyelination and axonal damage in the brain and spinal cord. Since there is currently no treatment for this condition, the goal of rehabilitation is to assist people with their manifestations. Over the last decade, exergaming with commercial consoles has demonstrated potential benefits in managing motor and functional impairments. However, new videogame strategies and assessment in randomized controlled trials are necessary to obtain significant results in different outcomes.
The hypothesis is that the exergaming systems in addition to conventional treatment will show statistically significant improvements on motor skills, spasticity, and quality of life results compared to conventional therapy alone. Therefore, this project aims to evaluate the effectiveness of two different exergaming systems in addition to conventional treatment on physical functional capacity, balance, muscle strength, spasticity in lower limbs and quality of life compared to an isolated conventional intervention in patients with multiple sclerosis. The investigators here design a multi-center, assessor-blind, 24-weeks, randomized controlled trial protocol. The achievement of the present project would serve to analyze the benefits of an alternative exercise program in the motor and functional rehabilitation program of multiple sclerosis patients and to identify the subjects in whom the benefits would be greater and whose implementation would have greater priority.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
(i) Diagnosis of MS in any of its types (clinically isolated syndrome, relapsing-remitting MS, primary progressive MS or secondary progressive MS) based on the McDonald criteria.
(ii) Age over 18 years.
(iii) Mini-Mental State Examination score > 19 points.
(iv) Score on the Expanded Disability Status Scale (EDSS) under 7.0 points.
Exclusion criteria
(i) Diagnosis of another disease that affects balance and/or coordination.
(ii) Exacerbation or steroid treatment in the 30 days prior to inclusion in the study.
(iii) Presence of visual deficits.
Primary purpose
Allocation
Interventional model
Masking
36 participants in 3 patient groups
Loading...
Central trial contact
Alvaro Alba Rueda, PhD student
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal